Something @Pledge will love to hear:
"Patient enrolment is now approximately 20% complete. Although the rate of recruitment has accelerated substantially, following the opening of numerous additional clinical centres, the Company now anticipates enrolment continuing into 2025. Release of the primary results is still anticipated by late 2025."
Surely a reason to celebrate, unless you suffer from High Risk aGvHD.
- Forums
- ASX - By Stock
- Ann: Quarterly Activity Report & Appendix 4C
CYP
cynata therapeutics limited
Add to My Watchlist
6.25%
!
17.0¢

Something @Pledge will love to hear:"Patient enrolment is now...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
0.010(6.25%) |
Mkt cap ! $38.41M |
Open | High | Low | Value | Volume |
16.0¢ | 17.5¢ | 16.0¢ | $45.60K | 278.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 62994 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 107450 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 62994 | 0.160 |
4 | 66451 | 0.155 |
2 | 55000 | 0.150 |
2 | 45937 | 0.140 |
1 | 25000 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 107450 | 3 |
0.180 | 113494 | 5 |
0.185 | 35990 | 1 |
0.190 | 8868 | 1 |
0.195 | 22055 | 2 |
Last trade - 15.17pm 18/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online